4//SEC Filing
Sanders Corazon (Corsee) D. 4
Accession 0001796536-25-000005
CIK 0001651308other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:57 PM ET
Size
12.1 KB
Accession
0001796536-25-000005
Insider Transaction Report
Form 4
Sanders Corazon (Corsee) D.
Director
Transactions
- Exercise/Conversion
American Depositary Shares
2025-11-26$159.03/sh+2,627$417,772→ 2,627 total - Sale
American Depositary Shares
2025-11-26$340.20/sh−1,823$620,185→ 804 total - Sale
American Depositary Shares
2025-11-26$342.47/sh−804$275,349→ 0 total - Exercise/Conversion
Share Option (Right to Buy)
2025-11-26−34,151→ 0 totalExercise: $12.23Exp: 2034-06-04→ Ordinary Shares (34,151 underlying)
Holdings
- 57,226
Ordinary Shares
Footnotes (5)
- [F1]Each American Depositary Share represents 13 Ordinary Shares.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.04 to $340.68, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.42 to $342.675, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F4]The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
- [F5]The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors (the "Board") or otherwise ceases to serve as a director, unless the Board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.
Documents
Issuer
BeOne Medicines Ltd.
CIK 0001651308
Entity typeother
Related Parties
1- filerCIK 0001796536
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:57 PM ET
- Size
- 12.1 KB